The major objective of this project has been to study neutrophil function in health and disease. Determination of the biochemical and genetic basis of inherited diseases affecting phagocytes and associated with recurrent infections, and the diagnosis and treatment of these diseases is a major component of this project. Also within the scope of this project is the study of in vitro model systems of these inherited diseases using preparations of phagocytic cells derived from normal volunteers and patients. We have shown that Chronic Granulomatous Diseases (CGD) are a heterogeneous group of diseases resulting from absent H202 production by phagocytes, associated with recurrent infections. The X-lined form results from a defect in the gene coding for the 91 kDa subunit of cytochrome b. We show that different kindreds have different lesions of this gene, in that some patients make no mRNA coding for this protein, others make mRNA but no protein, while some make a functionally defective protein. These observations suggest that the gene defect may be a new mutation in may kindreds and that mutations occur at different sites. We have recently shown that there are two forms of cytochrome b-positive, autosomal recessive CGD. The most common form is missing a 47 kDa cytosol protein, whose phosphorylation plays a role in activation of neutrophils oxidative metabolism. We have demonstrated that the lesion responsible for neutrophil specific granule deficiency is a differentiation stage specific lesion in myeloid cell gene regulation. In particular, there is a failure of lactoferrin mRNA production in myeloid cells, but lactoferrin is synthesized normally in nasal secretions of specific granule deficient patients.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000155-14
Application #
3818118
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Niaid Extramural Activities
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Sobhanie, Mahdee; Matsuoka, Yumiko; Jegaskanda, Sinthujan et al. (2016) Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9). J Infect Dis 213:922-9
O'Donnell, Christopher D; Vogel, Leatrice; Matsuoka, Yumiko et al. (2014) The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines. J Virol 88:12374-84
Baz, Mariana; Luke, Catherine J; Cheng, Xing et al. (2013) H5N1 vaccines in humans. Virus Res 178:78-98
Talaat, Kawsar R; Karron, Ruth A; Luke, Catherine J et al. (2011) An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults. Vaccine 29:3144-8
Kuhns, Douglas B; Alvord, W Gregory; Heller, Theo et al. (2010) Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 363:2600-10
Talaat, Kawsar R; Karron, Ruth A; Callahan, Karen A et al. (2009) A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. Vaccine 27:3744-53
Karron, Ruth A; Talaat, Kawsar; Luke, Catherine et al. (2009) Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults. Vaccine 27:4953-60
Suguitan Jr, Amorsolo L; Marino, Michael P; Desai, Purvi D et al. (2009) The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus. Virology 395:280-8
Zarember, Kol A; Cruz, Anna R; Huang, Chiung-Yu et al. (2009) Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus. Antimicrob Agents Chemother 53:2654-6
De Ravin, Suk See; Shum, Elaine; Zarember, Kol A et al. (2008) Short stature in partially corrected X-linked severe combined immunodeficiency--suboptimal response to growth hormone. J Pediatr Endocrinol Metab 21:1057-63

Showing the most recent 10 out of 30 publications